AdvisorShares Pure US Cannabis ETF MSOS

The investment seeks long-term capital appreciation. The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology and life sciences industry group within the health care sector. The fund is non-diversified.

ARCA:MSOS - Post by User

AdvisorShares Pure US Cannabis ETF > MSOS and Rare Cannabinoids

<< Previous

Bullboard Posts

Next >>

Post by Bullknit101on Nov 17, 2021 12:08pm

80 Views

Post# 34136619

MSOS and Rare Cannabinoids

It's about time for breakout. InMed will be the go to address for minor cannabinoids to supply MSOs and big pharma who want to get going with Cnanabinoid clinical trials. https://finance.yahoo.com/quote/INM/

<< Previous

Bullboard Posts

Next >>

One of the strongest contenders to lead Canada’s cannabis market